Recent clinical trials have successfully slowed Alzheimer's disease dementia progression, but only in early-stage patients. Society must therefore shift to early diagnosis. By framing this is as an engineering design challenge, we argue that a systems approach will identify solutions by providing the means to validate dementia medical technologies from multiple levels and perspectives: society, government, public health, healthcare, and patient ecosystems. We show that new data-enabled design methods can facilitate these different granularities of thinking and outline the need for designers.
No takes yet. Share an insight, caveat, or question.
Newton et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: